Back to MW MARSHALL WACE, LLP

KLRSKLRS
6 quarters

Position history for MWMARSHALL WACE, LLP's holdings in KALARIS THERAPEUTICS INC

MARSHALL WACE, LLP holds 139,201 shares of KLRS (KALARIS THERAPEUTICS INC), worth $566,549 as of 2026-Q2. The position was increased (+105.1% shares). KLRS represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$566,549

Current Shares

139,201

Total Value Change

+$453,206

Total Shares Change

+125,086

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
139,201
+105.1%
$566,5490.0%$4.07
39
2026-Q1
Decreased
67,879
-6.9%
$391,6620.0%$9.42
0
2025-Q4
Increased
72,876
+416.3%
$615,0740.0%$8.38
39
2025-Q3
Unchanged
14,115
0.0%
$81,5850.0%$6.35
0
2025-Q2
Unchanged
14,115
0.0%
$37,6870.0%$2.62
0
2025-Q1
New
14,115
-
$113,3430.0%$8.60
30

Other major holders of KLRS: RTW INVESTMENTS, LP, Alyeska Investment Group, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used